Featured Research

from universities, journals, and other organizations

Caffeine-based gold compounds are potential tools in fight against cancer

Date:
February 26, 2014
Source:
American Chemical Society
Summary:
The side effects of ingesting too much caffeine -- restlessness, increased heart rate, having trouble sleeping -- are well-known, but recent research has shown that the stimulant also has a good side. It can kill cancer cells. Now, researchers report that combining a caffeine-based compound with a small amount of gold could someday be used as an anti-cancer agent.

The side effects of ingesting too much caffeine -- restlessness, increased heart rate, having trouble sleeping -- are well known, but recent research has shown that the stimulant also has a good side. It can kill cancer cells. Now, researchers report in the ACS journal Inorganic Chemistry that combining a caffeine-based compound with a small amount of gold could someday be used as an anticancer agent.

Angela Casini, Michel Picquet and colleagues note that caffeine and certain caffeine-based compounds have recently been in the spotlight as possible anticancer treatments. But drinking gallons of coffee, sodas and energy drinks isn't the solution. And the regular caffeine in these drinks would start to have negative effects on healthy cells, too, at the levels necessary to kill cancerous ones. Gold also can wipe out cancer cells, but, like caffeine, it can harm healthy cells. So, the research team put the two together into certain configurations to see whether the new caffeine-based gold compounds could selectively stop cancer cells from growing without hurting other cells.

They made a series of seven new compounds, called caffeine-based gold (I) N-heterocyclic carbenes, in the laboratory and studied them. The scientists found that, at certain concentrations, one of the compounds of the series selectively killed human ovarian cancer cells without harming healthy cells. In addition, the compound targeted a type of DNA architecture, called "G-quadruplex," that is associated with cancer.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Benoξt Bertrand, Loic Stefan, Marc Pirrotta, David Monchaud, Ewen Bodio, Philippe Richard, Pierre Le Gendre, Elena Warmerdam, Marina H. de Jager, Geny M.M. Groothuis, Michel Picquet, Angela Casini. Caffeine-Based Gold(I)N-Heterocyclic Carbenes as Possible Anticancer Agents: Synthesis and Biological Properties. Inorganic Chemistry, 2014; 53 (4): 2296 DOI: 10.1021/ic403011h

Cite This Page:

American Chemical Society. "Caffeine-based gold compounds are potential tools in fight against cancer." ScienceDaily. ScienceDaily, 26 February 2014. <www.sciencedaily.com/releases/2014/02/140226101827.htm>.
American Chemical Society. (2014, February 26). Caffeine-based gold compounds are potential tools in fight against cancer. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2014/02/140226101827.htm
American Chemical Society. "Caffeine-based gold compounds are potential tools in fight against cancer." ScienceDaily. www.sciencedaily.com/releases/2014/02/140226101827.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) — Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) — America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) — China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:  

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile iPhone Android Web
          Follow Facebook Twitter Google+
          Subscribe RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins